Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$459,530
-$5,956,082 QoQ
Shares Held
1,269
-99.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#2,247
of 3,140 holders
Holding Since
Mar 2023
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Faithward Advisors, LLC holds $6,902,856 across 7 Drug Manufacturers - General names. AMGN ranks #5 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
7,824 | $1,987,061 | |
| 2 | ABBV |
AbbVie Inc.
|
6,192 | $1,558,154 | |
| 3 | MRK |
Merck & Co., Inc.
|
9,353 | $1,201,860 | |
| 4 | LLY |
ELI LILLY & Co
|
862 | $1,033,908 | |
| 5 | AMGN |
Amgen Inc
This page
|
1,269 | $459,530 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,229 | $407,951 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,415 | $254,392 |
All Filings in AMGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $459,530 | 1,269 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $6,415,612 | 132,492 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $449,396 | 1,373 | Shares | Sole | 2026-02-17 | |
| 2024-09-30 | $290,311 | 901 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $285,579 | 914 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $266,692 | 938 | Shares | Sole | 2024-05-15 | |
| 2023-03-31 | $514,927 | 2,130 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||